Full text is available at the source.
Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism
Orexin-A worsens memory problems in Alzheimer's mice by harming brain cell connections and changing amyloid beta processing
AI simplified
Abstract
Orexin-A (OXA) aggravates memory impairments and circadian rhythm disturbances in 3xTg-AD mice.
- OXA is linked to increased amyloid beta (Aβ) levels and tau pathologies in 3xTg-AD mice.
- Cognitive deficits are exacerbated by OXA, affecting both memory and synaptic plasticity.
- Hippocampal long-term potentiation (LTP) depression is worsened by OXA treatment.
- OXA influences the expression of BACE1 and NEP, which are involved in Aβ production and clearance.
- Disruption of circadian rhythms and the sleep-wake cycle may underlie the cognitive effects of OXA.
AI simplified